Matrix extracellular phosphoglycoprotein causes phosphaturia in rats by inhibiting tubular phosphate reabsorption

Nephrology Dialysis Transplantation

Volumn 23, Issue 2, 2008, Pages 730-733

  Dobbie, Hamish ^a   Unwin, Robert J ^a   Faria, Nuno J R ^a   Shirley, David G ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Kidney; Phosphatonin; Phosphaturia; Renal clearance

Indexed keywords

INULIN; MATRIX EXTRACELLULAR PHOSPHOGLYCOPROTEIN; PHOSPHATE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG EFFECT; GLOMERULUS FILTRATION RATE; KIDNEY CLEARANCE; KIDNEY TUBULE ABSORPTION; MALE; NONHUMAN; PHOSPHATURIA; PRIORITY JOURNAL; RAT; URINALYSIS;

ABSORPTION; ANIMALS; EXTRACELLULAR MATRIX PROTEINS; GLYCOPROTEINS; HYPOPHOSPHATEMIA, FAMILIAL; KIDNEY TUBULES; MALE; PHOSPHATES; PHOSPHOPROTEINS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 44449138422     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm535     Document Type: Article

References (20)

1. Rowe PS, de Zoysa PA, Dong R et al. MEPE, a new gene expressed in bone marrow and tumors causing osteomalacia. Genomics 2000; 67: 54-68
2. Petersen DN, Tkalcevic GT, Mansolf AL, Rivera-Gonzalez R, Brown TA. Identification of osteoblast/osteocyte factor 45 (OF45), a bone-specific cDNA encoding an RGD-containing protein that is highly expressed in osteoblasts and osteocytes. J Biol Chem 2000; 275: 36172-36180
3. Shimada T, Mizutani S, Muto T et al. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci USA 2001; 98: 6500-6505
4. De Beur SM, Finnegan RB, Vassiliadis J et al. Tumors associated with oncogenic osteomalacia express genes important in bone and mineral metabolism. J Bone Miner Res 2002; 17: 1102-1110
5. Argiro L, Desbarats M, Glorieux FH, Ecarot B. Mepe. the gene encoding a tumor-secreted protein in oncogenic hypophosphatemic osteomalacia, is expressed in bone. Genomics 2001; 74: 342-351
6. Blumsohn A. What have we learnt about the regulation of phosphate metabolism? Curr Opin Nephrol Hypertens 2004; 13: 397-401
7. Liu S, Brown TA, Zhou J et al. Role of matrix extracellular phosphoglycoprotein in the pathogenesis of X-linked hypophosphatemia. J Am Soc Nephrol 2005; 16: 1645-1653
8. White KE, Larsson TE, Econs MJ. The roles of specific genes implicated as circulating factors involved in normal and disordered phosphate homeostasis: frizzled related protein-4, matrix extracellular phosphoglycoprotein, and fibroblast growth factor 23. Endocr Rev 2006; 27: 221-241
9. Jain A, Fedarko NS, Collins MT et al. Serum levels of matrix extracellular phosphoglycoprotein (MEPE) in normal humans correlate with serum phosphorus, parathyroid hormone and bone mineral density. J Clin Endocrinol Metab 2004; 89: 4158-4161
10. Rowe PS, Kumagai Y, Gutierrez G et al. MEPE has the properties of an osteoblastic phosphatonin and minhibin. Bone 2004; 34: 303-319
11. Namnum P, Insogna K, Baggish D, Hayslett JP. Evidence for bidirectional net movement of creatinine in the rat kidney. Am J Physiol 1983; 244: F719-F723
12. Walter SJ, Zewde T, Shirley DG. The effect of anaesthesia and standard clearance procedures on renal function in the rat. Q J Exp Physiol 1989; 74: 805-812
13. Faria NJR, Dobbie H, Slater JM, Shirley DG, Stocking CJ, Unwin RJ. Simultaneous determination of anions in nanoliter volumes. Kidney Int 2005; 67: 357-363
14. Baum M, Schiavi S, Dwarakanath V, Quigley R. Effect of fibroblast growth factor-23 on phosphate transport in proximal tubules. Kidney Int 2005; 68: 1148-1153
15. Imel EA, Econs MJ. Fibroblast growth factor 23: roles in health and disease. J Am Soc Nephrol 2005; 16: 2565-2575
16. Berndt T, Craig TA, Bowe AE et al. Secreted frizzled-related protein 4 is a potent tumor-derived phosphaturic agent. J Clin Invest 2003; 112: 785-794
17. Imel EA, Peacock M, Pitukcheewanont P et al. Sensitivity of fibroblast growth factor 23 measurements in tumor-induced osteomalacia. J Clin Endocrinol Metab 2006; 91: 2055-2061
18. Rowe PSN. The wrickkened pathways of FGF23, MEPE and PHEX. Crit Rev Oral Biol Med 2004; 15: 264-281
19. Liu S, Rowe PS, Vierthaler L, Zhou J, Quarles LD. Phosphorylated acidic serine-aspartate-rich MEPE-associated motif peptide from matrix extracellular phosphoglycoprotein inhibits phosphate regulating gene with homologies to endopeptidases on the X-chromosome enzyme activity. J Endocrinol 2007; 192: 261-267
20. Ogbureke KUE, Fisher LW. Renal expression of SIBLING proteins and their partner matrix metalloproteinases (MMPs). Kidney Int 2005; 68: 155-166